Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 427-440-1 | CAS number: 24487-91-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 August 1996 - 20 September 1996
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted to GLP in accordance with generally accepted scientific principles, possibly with incomplete reporting or methodological deficiencies, which do not affect the quality of the relevant results. Only four bacterial strains were tested during the study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- Only 4 strains of S. typhimurium were used.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 84-2
- GLP compliance:
- yes
- Remarks:
- Deviation from GLP: Chemical analysis of dosing solutions was not performed, however, the initial stock solution of the test compound was prepared gravimetrically by an experienced investigator and subsequent dilutions were prepared volumetrically.
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- -
- EC Number:
- 427-440-1
- EC Name:
- -
- Cas Number:
- 24487-91-0
- Molecular formula:
- C9H9ClO2
- IUPAC Name:
- 2-Methyl-3-methoxy benzoyl chloride
- Test material form:
- not specified
- Details on test material:
- MMBC
Constituent 1
Method
- Target gene:
- S. typhimurium: Histidine locus.
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- The tester strains were subcultured in Oxoid Nutrient Broth #2 for approximately 10 hr at 37 (±1) °C. The fresh inoculum was used when bacterial growth was approximately 10^8 to 10^9 cells per mL.
Control plates were run to check for sterility, determine the background reversion rate and measure the response of each tester strain to a positive control compound. - Additional strain / cell type characteristics:
- other: Strains were characterized for nutritional requirements, crystal violet sensitivity, and ampicillin resistance no more than 6 months prior to initiation of the study.
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 activation, derived from the livers of rats treated with Aroclor 1254.
- Test concentrations with justification for top dose:
- 0, 50, 200, 500, 2000 and 5000 µg/plate.
The initial stock solution of the test compound was prepared gravimetrically and subsequent dilutions were prepared volumetrically. Note: All concentrations were adjusted for active ingredient, - Vehicle / solvent:
- The test substance was dissolved in acetone.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- Details on test system and experimental conditions:
- POSITIVE CONTROLS
In the presence of metabolic activation: 2 µg/plate 2-anthramine for all four strains.
In the absence of metabolic activation: 3 µg/plate 2-nitrofluorene for strain TA98; 2 µg/plate sodium azide (SA) for strains TA100 and TA1535; 100 µg/plate 9-aminoacridine for strain TA1537.
METABOLIC ACTIVATION
The S-9 used for metabolic activation was obtained from rats treated with Aroclor. The S-9 mix consisted of the following:
Nicotinamide-adenine dinucleotide phosphate (NADP) 4 mM
Glucose-6-phosphate (G-6-P) 5 mM
Magnesium chloride (MgCl2) 8 mM
Potassium chloride (KCl) 33 mM
Sodium phosphate buffer, pH 7.4 100 mM
Liver homogenate (S-9) from Aroclor 1254 treated rats 10 %
The phosphate buffer mix used in the non-activated portion of the assay consisted of the above mix with an equal volume of saline substituted for NADP and S-9.
MUTAGENESIS ASSAY
The tester strains were subcultured in Oxoid Nutrient Broth #2 for approximately 10 hours at 37 (±1) °C. The fresh inoculum was used when bacterial growth was approximately 10^8 to 10^9 cells per mL.
Control plates were run to check for sterility, determine the background reversion rate and measure the response of each tester strain to a positive control compound.
For the activated portion of the assay the following were added, in order, to sterile test tubes: 2 mL of top agar, 0.1 mL of the bacteria inoculum, 0. 1 mL of the appropriate concentration of test substance, and 0.5 mL of phosphate buffer mix (with S-9 and NADP). For the non-activated portion of the assay, the above procedure was followed, except that the 0.5 mL of phosphate buffer mix (without S-9 or NADP) was added to the tubes directly after addition of the top agar. Each test article concentration was tested in triplicate, in minimal plates (minimal-glucose agar medium). The controls were tested in six replicates in minimal plates. The contents of the tubes were mixed and poured onto petri dishes containing approximately 20 mL of the appropriate agar. Plates were allowed to set for several minutes then placed in covered plastic boxes and incubated at 37 (±1) °C for approximately 72 hours prior to colony counting.
Following the incubation period, sterility plates were checked for contamination. Following the sterility check, the number of colonies on each plate was determined. The mean and standard deviation for each concentration was calculated. Background growth was checked for each experimental point to observe any toxic response. - Evaluation criteria:
- A mutagenicity assay is considered valid if the following conditions are met:
First, the spontaneous reversion rate, with and without metabolic activation, must be reasonably consistent with the expected range for the strain being used; i.e., 12-60 colonies per plate for TA98, 50-200 for TA100, 13-50 for TA1535, and 7-20 for TA1537. Second, the positive control materials must elicit a positive response. And third, strains must maintain their genotype, i.e., nutritional requirements, crystal violet sensitivity and ampicillin resistance.
A test substance is considered positive (mutagenic) if it elicits in independent assays a number of revertants per plate at least 2 times that observed in the solvent control (background). A response that does not meet this criterion but elicits a potential biologically significant response (e.g., a dose related increase in revertants per plate over 3 concentrations) is considered an equivocal response and requires further evaluation.
A test substance is considered negative (non-mutagenic) if the criteria for a positive assay were not met and the test substance was tested up to either 5,000 µg/plate, the limit of solubility, or the limit of toxicity. Toxicity is defined as the elimination of a uniform background lawn. - Statistics:
- Statistical methods beyond the calculation of the mean and standard deviation are not considered necessary for the interpretation of this study.
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- The positive control article for TA100 without metabolic activation (sodium azide) did not elicit a positive response in the initial assay. The response was elevated, but under 2 fold. A confirmatory assay was conducted. The positive control article for TA100 without metabolic activation did elicit a positive response in the confirmatory assay. A mutagenic response was not detected in any of the Salmonella tester strains examined.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1 Definitive Assay
Dose level (µg/plate) |
S-9 |
Mean Revertants/Plate and Standard deviation |
|||
TA98 |
TA100 |
TA1535 |
TA1537 |
||
Controls |
|||||
Acetone |
+ |
26 6 |
276 14 |
18 2 |
14 3 |
Acetone |
- |
22† 3 |
246 33 |
19† 5 |
13 3 |
2-ANTH 2 |
+ |
826* 22 |
1152* 33 |
279* 13 |
209* 41 |
2-NF 3 |
- |
492* 50 |
- |
- |
- |
SA 2 |
- |
- |
466 12 |
594* 46 |
- |
9-AA 100 |
- |
- |
- |
- |
163* 52 |
Test Substance |
|||||
5000 |
+ |
26† 0 |
260 22 |
21 2 |
14 2 |
2000 |
+ |
28 1 |
266 23 |
20 1 |
13 5 |
500 |
+ |
25 4 |
274 24 |
18 4 |
11 1 |
200 |
+ |
26 6 |
262 16 |
19 4 |
15 5 |
50 |
+ |
30 3 |
283 47 |
15 5 |
12 2 |
5000 |
- |
13 2 |
170 52 |
13 1 |
8 2 |
2000 |
- |
17 5 |
250 62 |
13 1 |
9 2 |
500 |
- |
19 2 |
229 35 |
17 4 |
16 5 |
200 |
- |
17 6 |
235 48 |
17 2 |
11 5 |
50 |
- |
23 6 |
229 32 |
19 4 |
11 2 |
*Positive Response (≥ 2 x solvent)
†Contaminated plate (excluded from calculations)
Table 2 Confirmatory Assay
Dose level (µg/plate) |
S-9 |
Mean Revertants/Plate and Standard deviation |
|||
TA98 |
TA100 |
TA1535 |
TA1537 |
||
Controls |
|||||
Acetone |
+ |
32 4 |
208 22 |
14 4 |
15 5 |
Acetone |
- |
29 5 |
200 12 |
22 3 |
13 3 |
2-ANTH 2 |
+ |
1194* 45 |
1335* 143 |
343* 18 |
257* 16 |
2-NF 3 |
- |
698* 102 |
- |
- |
- |
SA 2 |
- |
- |
504* 30 |
648* 26 |
- |
9-AA 100 |
- |
- |
- |
- |
431* 98 |
Test Substance |
|||||
5000 |
+ |
34 7 |
213 33 |
14 3 |
16 3 |
2000 |
+ |
35 5 |
221 9 |
14 6 |
15 4 |
500 |
+ |
31 4 |
229 8 |
16 0 |
15 4 |
200 |
+ |
32 6 |
235 7 |
14 3 |
11 3 |
50 |
+ |
30 2 |
236 15 |
14 4 |
13 2 |
5000 |
- |
15 2 |
209 54 |
16 2 |
7 3 |
2000 |
- |
20 4 |
263 36 |
24 3 |
12 1 |
500 |
- |
28 7 |
229 50 |
19 5 |
12 2 |
200 |
- |
25 4 |
200 29 |
20 2 |
14 5 |
50 |
- |
26 10 |
202 32 |
16 3 |
14 6 |
*Positive Response (≥ 2 x solvent)
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Under the conditions of the study, the test substance gave a negative (i.e. non mutagenic) response in Salmonella typhimurium strains TA98, TA100, TA1535 and TA1537 in the presence and absence of metabolic activation. - Executive summary:
The potential of the test substance to cause gene mutation in bacterial strains was determined in accordance with standardised guidelines US EPA OPP 84 -2, OECD 4714 and EU Method B.13. Four strains of Salmonella typhimurium (TA98, TA100, TA1535 and TA1537) were treated in the presence and absence of a rat liver derived metabolic activation system (S9 mix). The test substance was was evaluated at concentration ranging from 50 to 5000 µg/plate and the number of revertants was determined. The results were confirmed in an independent assay. During the study, the test substance did not induce an increase in revertants when compared to vehicle controls. This was true for all tester strains both with and without metabolic activation. Under the conditions of the study, the test substance was not mutagenic in the Salmonella gene mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.